-

AscellaHealth Releases Insights Document for Educational Webinar Series “From Evolution to Revolution: How the Rise of Specialty Pharmacy Drove a New PBM Model”

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a national specialty pharmacy benefit manager (SPBM™) serving commercial, Medicare and Medicaid segments, announces the release of its Insights Document based upon the AscellaHealth 2020 three-episode webinar series, “From Evolution to Revolution: How the Rise of Specialty Pharmacy Drove a New PBM Model.” This concise publication highlights webinar presentations from some of nation’s most respected thought leaders in the specialty pharmacy space, providing attendees with valuable guidance on ways that employers can help control specialty pharmacy costs and optimize a comprehensive service model to promote general wellness and improve quality of care.

“We’ve assembled key points from the webinar that offer critical insights raised during each episode,” says Dea Belazi, president and CEO, AscellaHealth. “With pharmaceutical manufacturers launching more high-cost specialty drugs and new PBM arrangements in evolving markets, stakeholders will gain new information to help them better manage medications for rare diseases.”

The Insights Document spans key areas:

  • Smart Plan Design - Meaningful member cost sharing that meets plan goals; incentives to choose lower cost options; plan language and carve-outs.
  • Comprehensive Utilization Management - Prior authorization, step therapy, drug exclusions, quantity limits.
  • PBM Contract Aligned with Plan Objectives - Lowest net cost, performance guarantees, plan flexibility, continued vigilance.
  • Specialty Pharmacy Carve-Out Solutions - Carving out specialty pharmacy can help plan sponsors mitigate risk, optimize plan performance and generate savings for the plan and its participants.

Belazi adds, “The webinar attracted unprecedented attention throughout the marketplace, with providers, payers and patients focused on the sheer number of Rx products, demand for new drugs, cost concerns and the constraints of a regulatory environment. We are grateful to our outstanding roster of speakers and the feedback from attendees was extremely positive. As we plan our next webinar series, there is already a robust list of interested participants.”

About AscellaHealth
AscellaHealth, a national specialty pharmacy benefit manager (SPBM™), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.

About Leaf Health
Leaf Health is a national consulting firm dedicated to supporting the mid-market with prescription drug program strategies. We support our partners with guiding on the latest in Rx funding alternatives, discounts and rebate programs available in the market for both the traditional pharmacy and medical benefit. Our focus is to introduce innovative strategies that allow our customers to grow by offering unique pharmacy program products and solutions to their customers or employees. Our team of experts apply their expertise in the context of client business situation and typically return a 20:1 ROI.

Contacts

Media:

Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

AscellaHealth


Release Summary
AscellaHealth Releases Insights Document for Webinar Series “From Evolution to Revolution: How the Rise of Specialty Pharmacy Drove a New PBM Model”
Release Versions

Contacts

Media:

Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

More News From AscellaHealth

AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies...

AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies

DUBLIN--(BUSINESS WIRE)--AscellaHealth, a global partner delivering customisable solutions for the specialty pharmaceutical industry, proudly announces its role as Gold Sponsor of the World Orphan Drug Congress Europe (WODC), 22-25 October 2024, Barcelona, Spain. During the event, AscellaHealth will exhibit its comprehensive suite of end-to-end solutions proven to streamline the specialty pharmaceutical commercialisation process for life science manufacturers worldwide. These solutions align wi...

AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Issues Impacting Life Sciences & Payers within the Specialty Healthcare...
Back to Newsroom